Goldman says buy this ASX 200 share for a 14% annual return

This overlooked stock could be a good option for investors according to the broker.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're on the lookout for some new portfolio additions, then it could be worth considering Qube Holdings Ltd (ASX: QUB).

That's the view of analysts at Goldman Sachs, which see a lot of value in the often overlooked ASX 200 share.

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.

Image source: Getty Images

Why is Qube an ASX 200 share to buy?

Firstly, if you're not familiar with the company, Qube is Australia's largest integrated provider of import and export logistics services.

It operates over 160 locations across Australia, New Zealand, and South East Asia. This includes its 50% interest in Patrick Terminals, which is Australia's leading container terminal operator.

Goldman Sachs notes that Qube has successfully evolved into one of the country's premier logistics businesses. It said:

Over the past ~17 years, Qube has evolved—organically and through numerous acquisitions—into one of Australia's premier logistics businesses. Its holistic, national suite of supply-chain services is largely unrivalled; its network has increased revenue opportunities with existing and new customers, and should promote organic wallet share growth.

Big returns

Goldman is tipping big returns from this ASX 200 share over the next 12 months.

It has initiated coverage on the company's shares with a buy rating and a $3.70 price target. Based on the current Qube share price of $3.30, this implies a potential upside of 12% for investors between now and this time next year.

In addition, the broker is forecasting fully franked dividends per share of 7.5 cents in FY 2024 and 7.65 cents in FY 2025. This equates to dividend yields of approximately 2.3% for investors across both years.

In total, this means that investors would receive a total return of approximately 14% for investors over the next 12 months if Goldman is on the money with its recommendation.

The broker believes that now is the time to buy this ASX 200 share due to its positive outlook and the historically low multiples it trades on. Goldman concludes:

Strong expectations, yet multiple below historic lows. Net-net, we expect LT GDP+ earnings growth and improving ROACE. Yet, QUB is trading below trough valuations relative to the market / peers. The post-covid multiple justifiably lowered as earnings grew to expectations, though valuation is now supportive with re-rate potential. Our 100% DCF method derives a 12-m TP of A$3.70 (~14% upside). Risks include weakening commodity demand, a slow Moorebank ramp and adverse industrial action. Initiate Buy.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »